Tigran's products are not for sale in the U.S.
- Anders Williamsson. Born 1954. Chairman of the Board. Elected to the Board in 2009. Anders has more than 30 years’ international experience in medical technology and life science, among others as CEO of HemoCue (medical technology company, Sweden) and as Board Member/Chairman of the Board in several medical technology companies.
- Sven-Erik Nilsson. Born 1941. Elected to the Board in 2002. Sven-Erik has worked within R&D at HemoCue (medical technology company, Sweden) and is since more than ten years a private investor in the field of medical technology.
- Staale Petter Lyngstadaas. Born 1962. Scientific Advisor. Elected to the Board in 2007. DDS, PhD in molecular biology. Staale Petter is professor and Head of the Department of biomaterials, Institute of Odontology, University of Oslo, Norway. Former Chief Scientific Officer at Biora (medical technology company, Sweden).
- Lars Magnus Bjursten. Born 1949. Elected to the Board in 2002. MD, PhD, Professor in Bioimplant Research at University of Lund, Sweden and Adjunct Professor at University of California, San Diego, USA.
- Arve Nilsson. Born 1961. Board member in Tigran since 2011. Arve holds a M.Sc. Econ in Finance and a B.Sc. i Economics. Arve has worked for Carnegie during 16 years, in Denmark and Great Britain. Private investor since 2008.
